DK1594895T3 - Vækstfaktorkomplekser og modulation af celle-migration og -vækst - Google Patents

Vækstfaktorkomplekser og modulation af celle-migration og -vækst

Info

Publication number
DK1594895T3
DK1594895T3 DK04708282.1T DK04708282T DK1594895T3 DK 1594895 T3 DK1594895 T3 DK 1594895T3 DK 04708282 T DK04708282 T DK 04708282T DK 1594895 T3 DK1594895 T3 DK 1594895T3
Authority
DK
Denmark
Prior art keywords
protein complexes
cell migration
growth
growth factor
vitronectin
Prior art date
Application number
DK04708282.1T
Other languages
Danish (da)
English (en)
Inventor
Zee Upton
Christopher Luke Towne
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Queensland filed Critical Univ Queensland
Application granted granted Critical
Publication of DK1594895T3 publication Critical patent/DK1594895T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
DK04708282.1T 2003-02-05 2004-02-05 Vækstfaktorkomplekser og modulation af celle-migration og -vækst DK1594895T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2003900481A AU2003900481A0 (en) 2003-02-05 2003-02-05 Synthetic modulators of cell migration and growth
PCT/AU2004/000117 WO2004069871A1 (en) 2003-02-05 2004-02-05 Growth factor complexes and modulation of cell migration and growth

Publications (1)

Publication Number Publication Date
DK1594895T3 true DK1594895T3 (da) 2011-12-12

Family

ID=30005181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04708282.1T DK1594895T3 (da) 2003-02-05 2004-02-05 Vækstfaktorkomplekser og modulation af celle-migration og -vækst

Country Status (13)

Country Link
US (1) US7659367B2 (enExample)
EP (3) EP2357195B1 (enExample)
JP (2) JP4717799B2 (enExample)
KR (2) KR101175687B1 (enExample)
CN (1) CN1774448B (enExample)
AT (1) ATE521636T1 (enExample)
AU (1) AU2003900481A0 (enExample)
CA (1) CA2515335C (enExample)
DK (1) DK1594895T3 (enExample)
ES (1) ES2372388T3 (enExample)
NZ (1) NZ541738A (enExample)
WO (1) WO2004069871A1 (enExample)
ZA (1) ZA200506991B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8871709B2 (en) * 2003-02-05 2014-10-28 Queensland University of Technolgy Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
AU2003903896A0 (en) 2003-07-28 2003-08-07 Queensland University Of Technology Skin regeneration system
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004037A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for culturing keratinocytes
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
CA2616863A1 (en) * 2005-07-29 2007-02-01 Australian Stem Cell Centre Limited Compositions and methods for growth of pluripotent cells
US20100076489A1 (en) * 2007-03-06 2010-03-25 Joshua Stopek Wound closure material
CA2678889A1 (en) * 2007-03-06 2008-09-12 Tyco Healthcare Group Lp Wound closure material
KR20110139736A (ko) 2009-03-19 2011-12-29 퀸스랜드 유니버시티 오브 테크놀로지 성장 인자 시그널링을 위한 표적 및 치료 방법
NZ600454A (en) * 2009-11-30 2014-10-31 Univ Queensland Fibronectin: growth factor chimeras
US9133266B2 (en) * 2011-05-06 2015-09-15 Wisconsin Alumni Research Foundation Vitronectin-derived cell culture substrate and uses thereof
PL2782598T3 (pl) * 2011-11-23 2021-03-08 In3Bio Ltd. Rekombinowane białka i ich zastosowania terapeutyczne
JP2016515587A (ja) * 2013-03-29 2016-05-30 メリマック ファーマシューティカルズ インコーポレーティッド 軟骨結合性融合タンパク質
KR101558498B1 (ko) 2013-04-26 2015-10-12 건국대학교 산학협력단 노년황반변성의 진단, 치료 및 예방용 조성물 및 노년황반변성에 대한 진단 방법
WO2015037622A1 (ja) * 2013-09-10 2015-03-19 富士フイルム株式会社 多能性幹細胞の培養方法、培養用キット及び多能性幹細胞培養用培地
WO2016105332A1 (en) * 2014-12-22 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US20170304178A1 (en) * 2014-12-23 2017-10-26 Avon Products, Inc. Peptides and Their Use in the Treatment of Skin
WO2016105360A1 (en) * 2014-12-23 2016-06-30 Avon Products, Inc. Peptides and their use in the treatment of skin
US11299531B2 (en) * 2015-03-11 2022-04-12 Allgenesis Biotherapeutics Inc. Fusion protein comprising a ligand binding domain of VEGF and PDGF
WO2019010533A1 (en) * 2017-07-12 2019-01-17 Factor Therapeutics Limited TREATMENT OF OCULAR DISORDERS
WO2023233340A1 (en) * 2022-06-02 2023-12-07 Avant Meats Company Limited Genetically engineered yeast cells, recombinant proteins produced thereof and applications thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US592904A (en) 1897-11-02 Drill
US4849338A (en) 1982-07-16 1989-07-18 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4843000A (en) 1979-12-26 1989-06-27 Syntex (U.S.A.) Inc. Simultaneous calibration heterogeneous immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5091513A (en) 1987-05-21 1992-02-25 Creative Biomolecules, Inc. Biosynthetic antibody binding sites
DE68923556T2 (de) 1988-07-15 1996-04-11 Central Sydnry Area Health Ser Säureempfindliche subeinheit eines insulinähnlichen wachstumfaktors-bindeprotein-komplexes.
US6090790A (en) 1989-12-14 2000-07-18 Eriksson; Elof Gene delivery by microneedle injection
JP2866134B2 (ja) * 1990-02-05 1999-03-08 寳酒造株式会社 機能性ポリペプチド
JPH06500014A (ja) 1990-07-25 1994-01-06 シンジーン，インコーポレイテッド 多数の核酸相補体を生成させる環状伸長法
US6054122A (en) 1990-11-27 2000-04-25 The American National Red Cross Supplemented and unsupplemented tissue sealants, methods of their production and use
JP2829405B2 (ja) * 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5958764A (en) 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
WO1994018232A1 (en) 1993-02-12 1994-08-18 Repligen Corporation Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same
US5422252A (en) 1993-06-04 1995-06-06 Becton, Dickinson And Company Simultaneous amplification of multiple targets
US5962427A (en) 1994-02-18 1999-10-05 The Regent Of The University Of Michigan In vivo gene transfer methods for wound healing
AUPM672594A0 (en) 1994-07-08 1994-08-04 Royal Children's Hospital Research Foundation A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders
US6143495A (en) 1995-11-21 2000-11-07 Yale University Unimolecular segment amplification and sequencing
US5752019A (en) 1995-12-22 1998-05-12 International Business Machines Corporation System and method for confirmationally-flexible molecular identification
US5835382A (en) 1996-04-26 1998-11-10 The Scripps Research Institute Small molecule mimetics of erythropoietin
US6077987A (en) 1997-09-04 2000-06-20 North Shore-Long Island Jewish Research Institute Genetic engineering of cells to enhance healing and tissue regeneration
WO1999047070A1 (en) 1998-03-18 1999-09-23 Wake Forest University Improved implantable biomaterials, compositions and methods for their preparation and uses thereof
US6436897B2 (en) 1998-06-01 2002-08-20 Celtrix Pharmaceuticals, Inc. Pharmaceutical formulations for IGF/IGFBP
JP2001190280A (ja) * 1999-02-19 2001-07-17 Terumo Corp コラーゲン結合性生理活性ポリペプチド
WO2000055206A1 (en) 1999-03-18 2000-09-21 The Hope Heart Institute Endothelial cell stimulation by a complex of fibronectin and vascular endothelial growth factor
JP2002060400A (ja) * 2000-08-17 2002-02-26 Terumo Corp コラーゲン結合活性および血管新生調節活性を有するハイブリッドポリペプチド
AUPR030900A0 (en) * 2000-09-22 2000-10-12 Queensland University Of Technology Growth factor complex

Also Published As

Publication number Publication date
EP1594895A1 (en) 2005-11-16
EP2357194A1 (en) 2011-08-17
KR20050103288A (ko) 2005-10-28
KR20120051747A (ko) 2012-05-22
US7659367B2 (en) 2010-02-09
ZA200506991B (en) 2006-06-28
JP2007523598A (ja) 2007-08-23
WO2004069871A1 (en) 2004-08-19
KR101179678B1 (ko) 2012-09-04
EP1594895B1 (en) 2011-08-24
US20060194292A1 (en) 2006-08-31
EP2357195B1 (en) 2016-06-29
CA2515335A1 (en) 2004-08-19
CN1774448A (zh) 2006-05-17
EP2357195A1 (en) 2011-08-17
JP4717799B2 (ja) 2011-07-06
KR101175687B1 (ko) 2012-08-22
ATE521636T1 (de) 2011-09-15
EP1594895A4 (en) 2007-05-09
NZ541738A (en) 2006-03-31
CN1774448B (zh) 2012-07-18
AU2003900481A0 (en) 2003-02-20
CA2515335C (en) 2013-07-30
HK1091216A1 (en) 2007-01-12
ES2372388T3 (es) 2012-01-19
JP2011120595A (ja) 2011-06-23

Similar Documents

Publication Publication Date Title
DK1594895T3 (da) Vækstfaktorkomplekser og modulation af celle-migration og -vækst
Bian et al. Hydrogels that mimic developmentally relevant matrix and N-cadherin interactions enhance MSC chondrogenesis
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
CY1119263T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της ασβεστοποιησεως των οστων
CY1111714T1 (el) Δεσμευτικες πρωτεϊνες αυξητικου παραγοντα ηπατοκυτταρων (hgf).
ATE552849T1 (de) Behandlungsverfahren unter verwendung von ctla-4 antikörpern
MX2020002921A (es) Anticuerpos para claudin6 y métodos para tratar el cáncer.
CR10147A (es) "ligandos que tienen especificidad de enlace para vegf y/o egfr y métodos de uso de los mismos"
WO2008096268A3 (en) Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgery
BR112012013035A2 (pt) fibronectina: quimeras do fator do crescimento
DK1615952T3 (da) Fremgangsmåder til behandling af betændelsestilstande med specifikke, til humant angiopoietin-2-bindende midler
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE348632T1 (de) Prion protein peptide und deren verwendung
DE60130797D1 (de) Verwendung von spezifischen erbb4 antagonisten zur behandlung von stenose
ATE439369T1 (de) Methode und zubereitung zur hemmung von angiogenese
ATE470672T1 (de) Verwendung von cupredoxin-proteine für krebstherapie
EA200801172A1 (ru) Лиганды, имеющие специфичность связывания в отношении рецептора эпидермального фактора роста (egfr) и/или сосудистого эндотелиального фактора роста (vegf), и способы их применения
DE602005026866D1 (de) Vewendung von dreidimensionalem kultiviertem gewebe zur behandlung von kongestivem herzversagen
BR112012030821A2 (pt) vitronectina:fator de crescimento quimeras queratinócitos
ATE528025T1 (de) Wachstumsfaktor-modifiziertes extrazelluläres matrixmaterial und verfahren zu seiner herstellung und verwendung
EP1499190A4 (en) METHODS OF TREATING LIVER DISEASES AND LIVER LESIONS USING GROWTH HORMONE AND FOXM1B PROTEIN
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
EP1218398A4 (en) ANTISENSE MODULATION OF P13 KINASE P110 BETA EXPRESSION
PT1064018E (pt) Utilizacao de dominios isolados de colagenio de tipo iv para modificar interaccoes celulares e teciduais
DE60319135D1 (de) Peptide, die die heparinbindungsdomäne von vegf und vegfr-2 binden